The PI3K‐AKT‐mTOR pathway is abnormally activated in various malignant tumors, including HCC, bladder, and endometrial cancer, and is considered the primary pathway for tumor cell survival.15, 16, 17. The gene discussed is MTOR; the disease is hepatocellular carcinoma.